Dynavax Technologies Corporation ( DVAX) - Stock Earnings
Stock symbol DVAX is outdated, potentially delisted? Maybe it is available on other exchange?
DVAX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | -96.1 million USD | 68.2 million USD |
| 2025Q2 | 18.7 million USD | 95.4 million USD |
| 2025Q3 | 26.9 million USD | 94.9 million USD |
DVAX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 293.2 million USD | 722.7 million USD |
| 2023 | -6.4 million USD | 232.3 million USD |
| 2024 | 27.3 million USD | 277.2 million USD |
DVAX
Price: $15.50
52 week price:
Earnings Per Share: -0.37 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 1.5 million
Ebitda: -21.6 millionMarket Capitalization: 1.8 billion